Disease | chronic myeloproliferative disease |
Symptom | C1516669|clonal evolution |
Sentences | 2 |
PubMedID- 25671252 | Conclusions: the order in which jak2 and tet2 mutations were acquired influenced clinical features, the response to targeted therapy, the biology of stem and progenitor cells, and clonal evolution in patients with myeloproliferative neoplasms. |
PubMedID- 24478400 | clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. |
Page: 1